Medifast (MED) Cash from Operations (2016 - 2025)
Medifast's Cash from Operations history spans 16 years, with the latest figure at 5278000.0 for Q4 2025.
- For Q4 2025, Cash from Operations fell 6.69% year-over-year to 5278000.0; the TTM value through Dec 2025 reached 6863000.0, down 71.96%, while the annual FY2025 figure was 6863000.0, 71.96% down from the prior year.
- Cash from Operations reached 5278000.0 in Q4 2025 per MED's latest filing, down from 12113000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 65326000.0 in Q1 2021 to a low of 7459000.0 in Q4 2021.
- Average Cash from Operations over 5 years is 23405550.0, with a median of 14434500.0 recorded in 2021.
- Peak YoY movement for Cash from Operations: soared 793.65% in 2022, then plummeted 147.02% in 2024.
- A 5-year view of Cash from Operations shows it stood at 7459000.0 in 2021, then skyrocketed by 793.65% to 51739000.0 in 2022, then crashed by 79.66% to 10522000.0 in 2023, then plummeted by 147.02% to 4947000.0 in 2024, then dropped by 6.69% to 5278000.0 in 2025.
- Per Business Quant, the three most recent readings for MED's Cash from Operations are 5278000.0 (Q4 2025), 12113000.0 (Q3 2025), and 3378000.0 (Q2 2025).